Congratulations to our Bone Marrow Transplant (BMT) team! The Cigna LifeSOURCE Transplant Network has rated the WVU Cancer Institute Osborn Hematopoietic Malignancy and Transplantation Program a Program of Excellence once again. Cigna, an insurance company WVU contracts with that allows patients to be transplanted at our facility, based the excellence designation on specific criteria and guidelines, including number and types of transplants, patient survival and disease status. “This validates that our program provides superior care,” says Sonia Leadmon, oncology quality coordinator at the Cancer Institute’s Mary Babb Randolph Cancer Center. WVU has been rated a Cigna Program of Excellence every year since 2014 and has received excellence designations from several other insurance companies for its BMT program.
In the 55 years since the first U.S. Surgeon General report on the health consequences of cigarette smoking, smoking has declined substantially. Despite this progress, however, it remains the leading preventable cause of morbidity and mortality worldwide. Smoking rates also remain disproportionally high and relatively unchanged among certain vulnerable populations.
WVU professor of Occupational and Environmental Health Sciences recently spoke with Public News Service about the cancellation of a study investigating the health impacts of mountaintop removal and other surface mining. Read the full story online.